ALFA Filings
Every announcement, straight from the exchange
Every Sudarshan Pharma Industries financial results announcement on NSE and BSE, newest first, each with its own page.
Time
4 announcements
Sudarshan Pharma Industries Ltd reported revenue from operations of ₹174.4 Cr (+20.0% YoY) and net profit of ₹5.6 Cr (+40.0% YoY) for Q1 FY27.
Sudarshan Pharma Industries Ltd reported revenue from operations of ₹220.9 Cr (+36.7% YoY) and net profit of ₹11.4 Cr (+54.1% YoY) for Q4 FY26.
Sudarshan Pharma Industries Ltd reported consolidated total income of ₹711.77 Crore for the financial year ended March 31, 2026. Consolidated net profit reached ₹23.30 Crore, up from ₹14.97 Crore in the previous year. The company successfully transitioned to Ind AS reporting during the period, reflecting strong operational growth and expanded financial transparency.
Sudarshan Pharma Industries Ltd reported net profit of ₹4.1 Cr (+41.4% YoY) for Q3 FY26.